Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 2, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2028

Conditions

Juvenile Dermatomyositis

Interventions

BIOLOGICAL

CD19-targetd CAR-T

Subjects underwent lymphocyte clearance chemotherapy and then received a single intravenous cell infusion

Trial Locations (1)

RECRUITING

Children's Hospital Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

lead

Chongqing Precision Biotech Co., Ltd

INDUSTRY